HealthEquity's High-Margin HSA Assets: Analyst's Perspective On Their Impact On Revenue

KeyBanc Capital Markets analyst Scott Schoenhaus reiterated an Overweight rating on the shares of  HealthEquity, Inc. HQY, with a price target of $85.

The analyst remains particularly bullish on the company's higher custodial yields (the analyst models 2.35% for this year and 2.90% for next year).

HealthEquity is well-positioned to grow revenue by gaining share within the Health Savings Accounts markets (both organically and opportunistically via acquisitions, albeit M&A likely pushed out), Schoenhaus notes. 

The company's growing, high-margin HSA assets should contribute to its healthy cash position, the analyst mentions.

For FY24, the analyst expects the company's revenue estimate to be $984.8 million, up from $967.5 million prior estimate.

FY24 adj. EBITDA is estimated to be $338.1 million vs. previous estimate of $324.4 million. 

For FY25, the analyst's revenue estimate will be $1.138 billion, higher than the previous expectation of $1.132 billion. FY25 adj. EBITDA estimate is now $439.3 million from the prior $426.6 million estimate. 

Price Action: HQY shares are trading lower by 1.7% to $63.70 on the last check Monday.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorEquitiesNewsPrice TargetReiterationMarketsAnalyst RatingsGeneralBriefsExpert Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!